Shannon M. Murray

Dr. Shannon M. Murray


Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 March 2020 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
SNShi Yong Neo
Shi Yong Neo
YYYing Yang
Ying Yang
JRJulien Record
Julien Record
RMRan Ma
Ran Ma
XCXinsong Chen
Xinsong Chen
ALAndreas Lundqvist
Andreas Lundqvist
High levels of ecto-5′-nucleotidase (CD73) have been implicated in immune suppression and tumor progression, and have also been observed in cancer patients who progress on anti–PD-1 immunotherapy. Although regulatory T cells can express CD73 and inhibit T cell responses via the production of adenosine, less is known about CD73 expression in other immune cell populations. We found that tumor-infiltrating NK cells upregulate CD73 expression and the frequency of these CD73-positive NK cells correlated with larger tumor size in breast cancer patients. In addition, the expression of multiple alternative immune checkpoint receptors including LAG-3, VISTA, PD-1, and PD-L1 was significantly higher in CD73-positive NK cells than in CD73-negative NK cells. Mechanistically, NK cells transport CD73 in intracellular vesicles to the cell surface and the extracellular space via actin polymerization–dependent exocytosis upon engagement of 4-1BBL on tumor cells. These CD73-positive NK cells undergo transcriptional reprogramming and upregulate IL-10 production via STAT3 transcriptional activity, suppressing CD4-positive T cell proliferation and IFN-γ production. Taken together, our results support the notion that tumors can hijack NK cells as a means to escape immunity and that CD73 expression defines an inducible population of NK cells with immunoregulatory properties within the tumor microenvironment.

15 September 2016 in Blood
Verified
Journal Article
Open access
PDF file
YMYumeng Mao
Yumeng Mao
VHVincent van Hoef
Vincent van Hoef
XZXiaonan Zhang
Xiaonan Zhang
EWErik Wennerberg
Erik Wennerberg
JLJulie Lorent
Julie Lorent
ALAndreas Lundqvist
Andreas Lundqvist
Key Points: Cytokine-activated NK cells display distinct gene expression programs in response to cytokine withdrawal. IL-15 sustains antitumor functions of NK cells through mTOR-governed metabolic processes.

1 August 2000 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
NSNi Huiping Son
Ni Huiping Son
SMShannon M. Murray
Shannon M. Murray
JYJack Yanovski
Jack Yanovski
RHRichard J. Hodes
Richard J. Hodes
NWNan-Ping Weng
Nan-Ping Weng
Age effects on telomere length and telomerase expression in peripheral blood lymphocytes were analyzed from 121 normal individuals age newborn to 94 years and revealed several new findings. 1) Telomere shortening was observed in CD4+ and CD8+ T and B cells with age. However, the rate of telomere loss was significantly different in these populations, 35 ± 8, 26 ± 7, and 19 ± 7 bp/year for CD4+ and CD8+ T and B cells, respectively. In addition, CD4+ T cells had the longest average telomeres at all ages, followed by B cells, with CD8+ T cell telomeres the shortest, suggesting that these lymphocyte populations may have different replicative histories in vivo. 2) Telomerase activity in freshly isolated T and B cells was indistinguishably low to undetectable at all ages but was markedly increased after Ag and costimulatory receptors mediated stimulation in vitro. Furthermore, age did not alter the magnitude of telomerase activity induced after stimulation of T or B lymphocytes through Ag and costimulatory receptors or in response to PMA plus ionomycin treatment. 3) The levels of telomerase activity induced by in vitro stimulation varied among individual donors but were highly correlated with the outcome of telomere length change in CD4+ T cells after Ag receptor-mediated activation. Together, these results indicate that rates of age-associated loss of telomere length in vivo in peripheral blood lymphocytes is specific to T and B cell subsets and that age does not significantly alter the capacity for telomerase induction in lymphocytes.

15 November 2010 in Journal of Virology
Verified
Journal Article
Closed access
SMShannon M. Murray
Shannon M. Murray
CDCarrie M. Down
Carrie M. Down
DBDavid Boulware
David Boulware
WSWilliam M. Stauffer
William M. Stauffer
WCWinston P. Cavert
Winston P. Cavert
DDDaniel C. Douek
Daniel C. Douek
Increased levels of activated T cells are a hallmark of the chronic stage of human immunodeficiency virus (HIV) infection and are highly correlated with HIV disease progression. We evaluated chloroquine (CQ) as a potential therapy to reduce immune activation during HIV infection. We found that the frequency of CD38 + HLA-DR + CD8 T cells, as well as Ki-67 expression in CD8 and CD4 T cells, was significantly reduced during CQ treatment. Our data indicate that treatment with CQ reduces systemic T-cell immune activation and, thus, that its use may be beneficial for certain groups of HIV-infected individuals.

11 July 2006 in Journal of Medical Primatology
Verified
Journal Article
Closed access
PDF file
SMShannon M. Murray
Shannon M. Murray
MLM.L. Linial
M.L. Linial

13 October 2014 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
AMArnaud Moris
Arnaud Moris
SMShannon M. Murray
Shannon M. Murray
SCSylvain Cardinaud
Sylvain Cardinaud
The AID/APOBEC cytidine deaminases participate in a diversity of biological processes from the regulation of protein expression to embryonic development and host defenses. In its classical role, AID mutates germline-encoded sequences of B cell receptors, a key aspect of adaptive immunity, and APOBEC1, mutates apoprotein B pre-mRNA, yielding two isoforms important for cellular function and plasma lipid metabolism. Investigations over the last ten years have uncovered a role of the APOBEC superfamily in intrinsic immunity against viruses and innate immunity against viral infection by deamination and mutation of viral genomes. Further, discovery in the area of HIV infection revealed that the HIV viral infectivity factor (Vif) protein interacted with APOBEC3G, targeting it for proteosomal degradation, overriding its antiviral function. More recently, our and others’ work have uncovered that the AID and APOBEC cytidine deaminase family members have an even more direct link between activity against viral infection and induction and shaping of adaptive immunity than previous thought, including that of antigen processing for cytotoxic T lymphocyte (CTL) activity and natural killer (NK) cell activation. Newly ascribed functions of these cytodine deaminases will be discussed, including their newly identified roles in adaptive immunity, epigenetic regulation, and cell differentiation. Herein this review we discuss AID and APOBEC cytodine deaminases as a link between innate and adaptive immunity uncovered by recent studies.